Heart Scan Market Research Report Information: By Types (Electron Beam Computed Tomography, Angiocardiography) Indication (Congenital Heart Disease, Coronary Arteries Blockage) End-User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast till 2030

Heart Scan Market Overview:

The heart scan market is anticipated to reach USD 12,435 Million by 2030 at 6.54% CAGR during the forecast period 2022-2030. A heart scan, sometimes called a coronary calcium scan, is a specialist X-ray diagnostic that produces pictures of the heart that may be used to detect and analyze calcium-containing plaque in the arteries. There has been a huge growth in demand for cardiovascular devices in recent years. According to the World Health Organization (WHO)

According to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die each year from heart disease, accounting for one out of every four deaths. In addition, the growing senior population and rising healthcare costs have fueled the market's expansion. On the other side, throughout the projection period, rigorous regulatory requirements and the high cost of diagnostic tests may hinder the expansion of the heart scan market.

Figure- Heart Scan Market, by region 2016(%)  

Intended Audience

• Cardiovascular Products Manufacturers


• Cardiovascular Products Providers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Research Methodology

Source: U.S. National Library of Medicine, U.S. Food and Drug Administration, U.S. Department of Health and Human Services, National Institutes of Health, Expert Interview, Annual report, White paper, Company Presentation, MRFR Analysis

Segments      

The heart scan market has been segmented on the basis of types,indication and end users.

On the basis of the types, the heart scan market is segmented into electron beam computed tomography, nuclear heart scan, echocardiogram, cardiac catheterization, coronary arteriography, angiocardiography, and others.

Based on the indication, it is segmented into congenital heart disease, coronary arteries blockage, defects or injury to the heart’s four primary valves, blood clots within the heart’s chambers, tumors in or on the heart, and others. On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, cardiac care centers, ambulatory centers & home care, academic institutes, and others. 

Regional Analysis                 

The Americas accounted for the major share of the market owing to the presence of a huge population of patients suffering from cardiovascular diseases, high healthcare expenditure, well-developed technology, and the presence of the leading players. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the heart scan market in the Americas. Europe accounted for the second largest market for the heart scan, which is followed by Asia Pacific. Increasing prevalence of the cardiovascular diseases, diabetes, and huge healthcare spending are the major driving factors that have boosted the market growth. Additionally, the healthcare expenditure in this region is also rising. People and healthcare organizations in this region are able to afford the high cost of the cardiovascular devices, which is driving the growth of the market. Furthermore, increasing government support and funding for the development and improvement of the treatments have fuelled the growth of the market. Asia Pacific is the fastest growing heart scan market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region. The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African heart scan market are increasing aging population and increasing number of diabetic and cardiovascular patients.Recent Development

St. Jude Medical LLC (St. Jude Medical), a subsidiary of Abbott Laboratories, is a cardiovascular medical device researcher, manufacturer, and distributor. CRT devices, implantable cardioverter defibrillators (ICDs), remote monitoring systems, cardiac mapping and pacemakers, visualization systems, catheter-based ablation devices, spinal cord stimulation, structural heart products, peripheral nerve stimulation, and deep brain stimulation devices are among the company's products. St. Jude Medical is based in St. Paul, Minnesota, in the United States.

Teleflex Inc (Teleflex) is a company that creates, develops, manufactures, and distributes disposable medical equipment for use in critical care and surgery. Circuits, masks, bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptors, and connections are among the company's main products. The company's products are used in vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine, and respiratory care, among other sectors. Teleflex is based in Wayne, Pennsylvania, in the United States.

Key players in the heart scan market: 

Some of the major players in this market are Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan) and others.